Advertisement

Chromoendoscopy

  • Ammar O. Kheir
  • Roy Soetikno
  • Tonya KaltenbachEmail author
Chapter
  • 555 Downloads

Abstract

Gastrointestinal cancers represent the leading cause of cancer-related death worldwide. The detection, diagnosis, and treatment of precursor and early gastrointestinal cancers are critical for improvements in morbidity and mortality. Often subtle in appearance, these pre- and early cancers can pose a challenge to endoscopic visualization with white light. Image enhancement using chromoendoscopy, through the application of dye solutions, has been shown to facilitate visualization to improve endoscopic localization, characterization, and therapy. In this review, we will focus on the techniques and tools of chromoendoscopy available in the United States including Lugol’s solution for squamous cell carcinoma of the esophagus, and indigo carmine and methylene blue for high-risk surveillance populations such as Barrett’s esophagus, inflammatory bowel disease, and hereditary nonpolyposis colorectal cancer syndrome.

Keywords

Endoscopy Colonoscopy Surveillance Image-enhanced endoscopy Lugol’s solution Indigo carmine Methylene blue Gastrointestinal cancer Dysplasia Inflammatory bowel disease Barrett’s esophagus 

Supplementary material

Video 3.1

Lugol’s esophageal squamous cell high grade dysplasia (MP4 11,489 kb)

Video 3.2

Indigo carmine preparation (MP4 28,426 kb)

Video 3.3

Chromoendoscopy technique (MP4 59,081 kb)

References

  1. 1.
    Kaltenbach T, Sano Y, Friedland S, Soetikno R, American Gastroenterological Association. American Gastroenterological Association (AGA) Institute technology assessment on image-enhanced endoscopy. Gastroenterology. 2008;134(1):327–40.CrossRefPubMedGoogle Scholar
  2. 2.
    Subramanian V, Ragunath K. Advanced endoscopic imaging: a review of commercially available technologies. Clin Gastroenterol Hepatol. 2014;12(3):368–76. e1.CrossRefPubMedGoogle Scholar
  3. 3.
    Committee AT, Wong Kee Song LM, Adler DG, Chand B, Conway JD, Croffie JM, et al. Chromoendoscopy. Gastrointest Endosc. 2007;66(4):639–49.CrossRefGoogle Scholar
  4. 4.
    Trivedi PJ, Braden B. Indications, stains and techniques in chromoendoscopy. QJM. 2013;106(2):117–31.CrossRefPubMedGoogle Scholar
  5. 5.
    Shiozaki H, Tahara H, Kobayashi K, Yano H, Tamura S, Imamoto H, et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer. 1990;66(10):2068–71.CrossRefPubMedGoogle Scholar
  6. 6.
    Meyer V, Burtin P, Bour B, Blanchi A, Cales P, Oberti F, et al. Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? Gastrointest Endosc. 1997;45(6):480–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Hashimoto CL, Iriya K, Baba ER, Navarro-Rodriguez T, Zerbini MC, Eisig JN, et al. Lugol’s dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol. 2005;100(2):275–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Fagundes RB, de Barros SG, Putten AC, Mello ES, Wagner M, Bassi LA, et al. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus. Endoscopy. 1999;31(4):281–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Dubuc J, Legoux JL, Winnock M, Seyrig JA, Barbier JP, Barrioz T, et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 french endoscopy centers. Endoscopy. 2006;38(7):690–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Yokoyama A, Ohmori T, Makuuchi H, Maruyama K, Okuyama K, Takahashi H, et al. Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer. 1995;76(6):928–34.CrossRefPubMedGoogle Scholar
  11. 11.
    Shimizu Y, Omori T, Yokoyama A, Yoshida T, Hirota J, Ono Y, et al. Endoscopic diagnosis of early squamous neoplasia of the esophagus with iodine staining: high-grade intra-epithelial neoplasia turns pink within a few minutes. J Gastroenterol Hepatol. 2008;23(4):546–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010;28(9):1566–72.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Sharma P, Weston AP, Topalovski M, Cherian R, Bhattacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus. Gut. 2003;52:24–7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Connor MJ, Sharma P. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia. Thorac Surg Clin. 2004;14(1):87–94.CrossRefPubMedGoogle Scholar
  15. 15.
    Sturm MB, Wang TD. Emerging optical methods for surveillance of Barrett’s oesophagus. Gut. 2015;64(11):1816–23.CrossRefPubMedGoogle Scholar
  16. 16.
    Pech O, Gossner L, Manner H, May A, Rabenstein T, Behrens A, et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy. 2007;39(7):588–93.CrossRefPubMedGoogle Scholar
  17. 17.
    Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4(5):566–72.CrossRefPubMedGoogle Scholar
  18. 18.
    Qumseya BJ, Wang H, Badie N, Uzomba RN, Parasa S, White DL, et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett’s esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2013;11(12):1562–70. e1–2.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kaltenbach T, Soetikno R. Image-enhanced endoscopy is critical in the detection, diagnosis, and treatment of non-polypoid colorectal neoplasms. Gastrointest Endosc Clin N Am. 2010;20(3):471–85.CrossRefPubMedGoogle Scholar
  20. 20.
    Soetikno R, Subramanian V, Kaltenbach T, Rouse RV, Sanduleanu S, Suzuki N, et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology. 2013;144(7):1349–52. e1–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148(3):639–51. e28.CrossRefPubMedGoogle Scholar
  22. 22.
    Picco MF, Pasha S, Leighton JA, et al. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis. 2013;19:1913–20.PubMedGoogle Scholar
  23. 23.
    Mohammed N, Kant P, Abid F, Rotimi O, Prasad P, Hamlin J, et al. High definition white light endoscopy (Hdwle) versus high definition with chromoendoscopy (Hdce) in the detection of dysplasia in long standing ulcerative colitis: a randomized controlled trial. Gastrointest Endosc. 2015;81(5):AB148.CrossRefGoogle Scholar
  24. 24.
    Committee ASP, Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81(5):1101–21. e1-13.CrossRefGoogle Scholar
  25. 25.
    Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–89.CrossRefPubMedGoogle Scholar
  26. 26.
    Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohn’s Colitis. 2013;7(12):982–1018.CrossRefGoogle Scholar
  27. 27.
    Lecomte T, Cellier C, Meatchi T, Barbier JP, Cugnenc PH, Jian R, et al. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol. 2005;3(9):897–902.CrossRefPubMedGoogle Scholar
  28. 28.
    Huneburg R, Lammert F, Rabe C, Rahner N, Kahl P, Buttner R, et al. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy. 2009;41(4):316–22.CrossRefPubMedGoogle Scholar
  29. 29.
    Bartel MJ, Picco MF, Wallace MB. Chromocolonoscopy. Gastrointest Endosc Clin N Am. 2015;25(2):243–60.CrossRefPubMedGoogle Scholar
  30. 30.
    Pohl J, Schneider A, Vogell H, Mayer G, Kaiser G, Ell C. Pancolonic chromoendoscopy with indigo carmine versus standard colonoscopy for detection of neoplastic lesions: a randomised two-centre trial. Gut. 2011;60(4):485–90.CrossRefPubMedGoogle Scholar
  31. 31.
    Brown SR, Baraza W. Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum. Cochrane Database Syst Rev. 2010;10:CD006439.Google Scholar
  32. 32.
    Fry S, Fleischer DE, Axelrad AM, et al. High-resolution chromoendoscopy: an affordable and accurate non-biopsy technique for predicting histology of colorectal polyps. Gastrointest Endosc. 1996;43:365.CrossRefGoogle Scholar
  33. 33.
    Eisen GM, Kim CY, Fleischer DE, Kozarek RA, Carr-Locke DL, Li TCM, et al. High-resolution chromoendoscopy for classifying colonic polyps: a multicenter study. Gastrointest Endosc. 2002;55(6):687–94.CrossRefPubMedGoogle Scholar
  34. 34.
    Longcroft-Wheaton G, Brown J, Cowlishaw D, Higgins B, Bhandari P. High-definition vs. standard-definition endoscopy with indigo carmine for the in vivo diagnosis of colonic polyps. United European Gastroenterol J. 2013;1(6):425–9.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Kudo S, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc. 1996;44:8–14.CrossRefPubMedGoogle Scholar
  36. 36.
    Fu KI, Sano Y, Kato S, Fujii T, Nagashima F, Yoshino T, et al. Chromoendoscopy using indigo carmine dye spraying with magnifying observation is the most reliable method for differential diagnosis between non-neoplastic and neoplastic colorectal lesions: a prospective study. Endoscopy. 2004;36(12):1089–93.CrossRefPubMedGoogle Scholar
  37. 37.
    Axelrad AM, Fleischer DE, Geller AJ, Nguyen CC, Lewis JH, Al-Kawas FH, et al. High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening. Gastroenterology. 1996;110(4):1253–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Monkemuller K, Wilcox CM. Interventional chromoendoscopy. Gastrointest Endosc. 2013;78(2):346–50.CrossRefPubMedGoogle Scholar
  39. 39.
    Holt BA, Jayasekeran V, Sonson R, Bourke MJ. Topical submucosal chromoendoscopy defines the level of resection in colonic EMR and may improve procedural safety (with video). Gastrointest Endosc. 2013;77(6):949–53.CrossRefPubMedGoogle Scholar
  40. 40.
    Kondo H, Fukuda H, Ono H, Gotoda T, Saito D, Takahiro K, et al. Sodium thiosulfate solution spray for relief of irritation caused by Lugol’s stain in chromoendoscopy. Gastrointest Endosc. 2001;53(2):199–202.CrossRefPubMedGoogle Scholar
  41. 41.
    Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s oesophagus. Lancet. 2003;362(9381):373–4.CrossRefPubMedGoogle Scholar
  42. 42.
    Davies J, Burke D, Olliver JR, Hardie LJ, Wild CP, Routledge MN. Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopy. Gut. 2007;56(1):155–6.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med. 1971;75(1):83–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Ginimuge PR, Jyothi SD. Methylene blue: revisited. J Anaesthesiol Clin Pharmacol. 2010;26(4):517–20.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Rehman UR. Methemoglobinemia. West J Med. 2001;175:193–6.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Ammar O. Kheir
    • 1
    • 2
  • Roy Soetikno
    • 3
    • 4
    • 5
  • Tonya Kaltenbach
    • 6
    Email author
  1. 1.Department of GastroenterologyQueen Elizabeth II Jubilee HospitalBrisbaneAustralia
  2. 2.School of Medicine and Public HealthUniversity of NewcastleNewcastleAustralia
  3. 3.Department of Gastroenterology and HepatologySingapore General HospitalSingaporeSingapore
  4. 4.National Cancer Center SingaporeSingaporeSingapore
  5. 5.Duke–National University Singapore Graduate Medical SchoolSingaporeSingapore
  6. 6.Veteran Affairs Palo Alto Health Care System and Stanford University School of MedicinePalo AltoUSA

Personalised recommendations